DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB06539
| null |
ZD4407
|
166882-70-8
|
2NV5BTN3UD
|
1,3-DIHYDRO-1-METHYL-5-((4-((2S,4R)-TETRAHYDRO-4-HYDROXY-2-METHYL-2H-PYRAN-4-YL)-2-THIENYL)THIO)-2H-INDOL-2-ONE | 2H-INDOL-2-ONE, 1,3-DIHYDRO-1-METHYL-5-((4-((2S,4R)-TETRAHYDRO-4-HYDROXY-2-METHYL-2H-PYRAN-4-YL)-2-THIENYL)THIO)- | 2H-INDOL-2-ONE, 1,3-DIHYDRO-1-METHYL-5-((4-(TETRAHYDRO-4-HYDROXY-2-METHYL-2H-PYRAN-4-YL)-2-THIENYL)THIO)-, (2S-TRANS)- | 5-(4-((2S,4R)-4-HYDROXY-2-METHYLOXAN-4-YL)THIOPHEN-2-YL)SULFANYL-1-METHYL-3H-INDOL-2-ONE
| null |
DB06540
| null |
AZD2315
|
457937-78-9
|
P9VFO1RY1N
|
L-ALANINAMIDE, N-(1-OXO-5-PHENYLPENTYL)-L-ALANYL-L-ARGINYL-L-ALANYL-(.ALPHA.S,3R)-3-AMINO-.ALPHA.-METHYL-2-OXO-1-PYRROLIDINEACETYL-L-ALANYL-L-ARGINYL-N-(4-(2-AMINO-2-OXOETHYL)PHENYL)-, ACETATE (1:2) | L-ALANINAMIDE, N-(1-OXO-5-PHENYLPENTYL)-L-ALANYL-L-ARGINYL-L-ALANYL-(.ALPHA.S,3R)-3-AMINO-.ALPHA.-METHYL-2-OXO-1-PYRROLIDINEACETYL-L-ALANYL-L-ARGINYL-N-(4-(2-AMINO-2-OXOETHYL)PHENYL)-, DIACETATE
| null |
DB06543
| null |
Astaxanthin
|
472-61-7
|
8XPW32PR7I
| null |
MQZIGYBFDRPAKN-UWFIBFSHSA-N
|
DB06544
| null |
MG98
| null | null | null | null |
DB06545
| null |
Gavilimomab
|
244096-20-6
|
TCR92293RC
|
Gavilimomab
| null |
DB06546
| null |
Atibuclimab
|
2417175-94-9
|
23IQ3PO968
|
Atibuclimab | IC14, (RECOMBINANT CHIMERIC MAB AGAINST HUMAN CD14) | IMMUNOGLOBULIN G4, ANTI-(HUMAN CD14 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL IC14 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IC14 .KAPPA.-CHAIN, DIMER
| null |
DB06548
| null |
Minodronic acid
|
180064-38-4
|
40SGR63TGL
|
Minodronate | Minodronic acid
|
VMMKGHQPQIEGSQ-UHFFFAOYSA-N
|
DB06549
| null |
Labradimil
|
159768-75-9
|
2MK663C346
|
Labradimil | Labradimilum
|
IDXCXSCCZNCXCL-XMADEQCMSA-N
|
DB06550
| null |
Bivatuzumab
| null |
0A0Z1IJN86
|
Bivatuzumab
| null |
DB06552
| null |
Anpocogin
| null |
3TTT9ZD93F
|
Recombinant nematode anticoagulant protein c2 | recombinant nematode anticoagulant protein c2 (rNAPc2) | Recombinant nematode anticoagulant protein-2 | rNAPc2
| null |
DB06553
| null |
R107474
|
214548-46-6
|
5KTD2O86CB
|
3-(2-(3,4-Dihydrobenzofuro(3,2-c)pyridin-2(1H)-yl)ethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one | 3-[2-(3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one | Lusaperidone
|
ZYXHQIPQIKTEDI-UHFFFAOYSA-N
|
DB06554
| null |
Gaboxadol
|
64603-91-4
|
K1M5RVL18S
|
4,5,6,7-tetrahydroisoxazolo(5,4-c)pyridin-3-ol | Gaboxadol | THIP
|
ZXRVKCBLGJOCEE-UHFFFAOYSA-N
|
DB06555
| null |
Siramesine
|
147817-50-3
|
3IX8CWR24V
|
Siramesine
|
XWAONOGAGZNUSF-UHFFFAOYSA-N
|
DB06556
| null |
Edifoligide
|
476273-48-0
|
4UG613F036
|
Edifoligide
| null |
DB06557
| null |
Lerdelimumab
|
285985-06-0
|
GX1FEU3QSM
|
Lerdelimumab
| null |
DB06558
| null |
Tezosentan
|
180384-57-0
|
64J9J55263
|
Tezosentan
|
TUYWTLTWNJOZNY-UHFFFAOYSA-N
|
DB06559
| null |
Lanimostim
|
117276-75-2
|
SXU0V4JP1R
|
4-221-Colony-stimulating factor 1 (human clone p3ACSF-69 reduced) | Lanimostim
| null |
DB06560
| null |
Pascolizumab
|
331243-22-2
|
N1IOA09R6A
|
Pascolizumab
| null |
DB06562
| null |
Emfilermin
|
159075-60-2
|
N70J8Y06YN
|
Emfilermin
| null |
DB06563
| null |
AM336
|
247207-64-3
|
2P1P5JB93S
|
LECONOTIDE | OMEGA-CONOPEPTIDE
| null |
DB06564
| null |
AM365
|
220984-26-9
|
088W05943X
|
2-((2-AMINO-9H-PURIN-9-YL)METHYL)PROPANE-1,3-DIOL | DETIVICICLOVIR
|
PIWJGZWZNOWIGH-UHFFFAOYSA-N
|
DB06566
| null |
RDP58
| null | null | null | null |
DB06568
| null |
alpha-Hydroxy glycineamide
| null | null |
aHGA | alfaHGA | alpha-HGA | alpha-hydroxy-glycineamide | alphaHGA | αHGA
| null |
DB06569
| null |
P-57AS3
|
384329-61-7
|
870A6Q6XVJ
| null |
CBMQKMMZBOSHHP-VXXSQTRDSA-N
|
DB06573
| null |
Rebimastat
|
259188-38-0
|
1B47R6ZX4K
|
Rebimastat
|
GTXSRFUZSLTDFX-HRCADAONSA-N
|
DB06575
| null |
Valomaciclovir
|
195157-34-7
|
F094Y61748
|
Valomaciclovir
|
ATSZELKUSAREPW-ZJUUUORDSA-N
|
DB06576
| null |
Baminercept
|
909110-25-4
|
HTV56CD308
|
Baminercept | Baminercept alfa
| null |
DB06578
| null |
Tonabersat
|
175013-84-0
|
2XD9773ZMN
|
Tonabersat
|
XLIIRNOPGJTBJD-ROUUACIJSA-N
|
DB06579
| null |
Adipiplon
|
840486-93-3
|
OPL214POJ1
|
Adipiplon
|
UAMAIHOEGLEXSV-UHFFFAOYSA-N
|
DB06580
| null |
Celgosivir
|
121104-96-9
|
895VG117HN
|
6-O-Butanoylcastanospermine | Celgosivir
|
HTJGLYIJVSDQAE-VWNXEWBOSA-N
|
DB06581
| null |
Bevirimat
|
174022-42-5
|
S125DW66N8
|
Bevirimat
|
YJEJKUQEXFSVCJ-WRFMNRASSA-N
|
DB06582
| null |
Dextofisopam
|
82059-50-5
|
EZ15I5D6C1
|
Dextofisopam | R-tofisopam
|
RUJBDQSFYCKFAA-HNNXBMFYSA-N
|
DB06584
| null |
TG4010
|
350485-85-7
|
WQQ9XZH2CC
|
MVA-Muc1-IL2
| null |
DB06585
| null |
Fipamezole
|
150586-58-6
|
T5RCK09KHV
|
Fipamezole
|
KXSUAWAUCNFBQJ-UHFFFAOYSA-N
|
DB06586
| null |
Cetilistat
|
282526-98-1
|
LC5G1JUA39
|
Cetilistat
|
MVCQKIKWYUURMU-UHFFFAOYSA-N
|
DB06587
| null |
Mitemcinal
|
154738-42-8
|
6X5NRJ664L
|
Mitemcinal
|
BELMMAAWNYFCGF-PZXAHSFZSA-N
|
DB06588
| null |
Triphendiol
|
1213777-80-0
|
6I62LZU21D
| null |
KQCJZAUNKSGEFM-UNMCSNQZSA-N
|
DB06589
| null |
Pazopanib
|
444731-52-6
|
7RN5DR86CK
|
Pazopanib | Pazopanibum
|
CUIHSIWYWATEQL-UHFFFAOYSA-N
|
DB06590
| null |
Ceftaroline fosamil
|
229016-73-3
|
7P6FQA5D21
|
(6R,7R)-7-[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Ceftarolina fosamilo | Ceftaroline | Ceftaroline fosamil | Ceftarolinum fosamilum
|
ZCCUWMICIWSJIX-NQJJCJBVSA-N
|
DB06592
| null |
Pegargiminase
|
1394129-74-8
|
0B7PYQ9YRT
|
ADI-PEG 20 | Arginine deiminase pegylated | Pegargiminase | Pegylated arginine deiminase
| null |
DB06594
| null |
Agomelatine
|
138112-76-2
|
137R1N49AD
|
Agomelatina | Agomelatine
|
YJYPHIXNFHFHND-UHFFFAOYSA-N
|
DB06595
| null |
Midostaurin
|
120685-11-2
|
ID912S5VON
|
4'-N-benzoylstaurosporine | Midostaurin
|
BMGQWWVMWDBQGC-IIFHNQTCSA-N
|
DB06596
| null |
TD101
| null | null | null | null |
DB06597
| null |
Estradiol sulfamate
|
172377-52-5
|
WO55ODW08Z
|
Estradiol 3-sulfamate | Estradiol-3-O-Sulfamate
|
YXYXCSOJKUAPJI-ZBRFXRBCSA-N
|
DB06598
| null |
Brostallicin
|
203258-60-0
|
RPC6R41K4I
|
Brostalicina | Brostallicin | Brostallicine | Brostallicinum
|
RXOVOXFAAGIKDQ-UHFFFAOYSA-N
|
DB06599
| null |
Lexatumumab
|
845816-02-6
|
967Q0SJD77
|
Lexatumumab
| null |
DB06600
| null |
Nemonoxacin
|
378746-64-6
|
P94L0PVO94
|
Nemonoxacin
|
AVPQPGFLVZTJOR-RYUDHWBXSA-N
|
DB06602
| null |
Reslizumab
|
241473-69-8
|
35A26E427H
|
Reslizumab
| null |
DB06603
| null |
Panobinostat
|
404950-80-7
|
9647FM7Y3Z
|
(2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide | 2-PROPENAMIDE, N-HYDROXY-3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)-, (2E)- | hydroxypropyl-B-cyclodextrin-panobinostat complex | Panobinostat | Panobinostatum
|
FPOHNWQLNRZRFC-ZHACJKMWSA-N
|
DB06604
| null |
Ilepatril
|
473289-62-2
|
5N1YAP5FCM
|
Ilepatril
|
FXKFFTMLFPWYFH-RDGPPVDQSA-N
|
DB06605
|
DB07828
|
Apixaban
|
503612-47-3
|
3Z9Y7UWC1J
|
apixabán | Apixaban | apixabanum
|
QNZCBYKSOIHPEH-UHFFFAOYSA-N
|
DB06606
| null |
Teplizumab
|
876387-05-2
|
S4M959U2IJ
|
hOKT3 gamma1(Ala-Ala) | Humanized OKT3 | Teplizumab-mzwv
| null |
DB06607
| null |
Catumaxomab
|
509077-98-9
|
M2HPV837HO
|
Catumaxomab
| null |
DB06608
| null |
Tafenoquine
|
106635-80-7
|
262P8GS9L9
|
Tafenoquine
|
LBHLFPGPEGDCJG-UHFFFAOYSA-N
|
DB06609
| null |
Odiparcil
|
137215-12-4
|
FIK1414ZI8
|
Odiparcil
|
JRHNIQQUVJOPQC-AQNFWKISSA-N
|
DB06610
|
DB06574
|
Omiganan
|
204248-78-2
|
618SLL9VBS
|
Omiganan
|
MVPAMLBUDIFYGK-BHDRXCTLSA-N
|
DB06611
| null |
Pegsunercept
|
330988-75-5
|
Q5I7SFZ853
|
Pegsunercept | sTNF-R1
| null |
DB06612
| null |
Mepolizumab
|
196078-29-2
|
90Z2UF0E52
|
Mepolizumab
| null |
DB06614
|
EXPT00645 | DB03655
|
Peramivir
|
330600-85-6
|
9ZS94HQO3B
|
Peramivir | Peramivir anhydrous
|
XRQDFNLINLXZLB-CKIKVBCHSA-N
|
DB06616
| null |
Bosutinib
|
380843-75-4
|
5018V4AEZ0
|
4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile | Bosutinib
|
UBPYILGKFZZVDX-UHFFFAOYSA-N
|
DB06618
| null |
Cutamesine
|
165377-43-5
|
9J7A4144BX
|
Cutamesine
|
UVSWWUWQVAQPJR-UHFFFAOYSA-N
|
DB06619
| null |
Amdoxovir
|
145514-04-1
|
54I81H0M9C
|
Amdoxovir | beta-D-2,6-Diaminopurine-dioxolane | DAPD
|
RLAHNGKRJJEIJL-RFZPGFLSSA-N
|
DB06620
| null |
Aplindore
|
189681-70-7
|
Q5O76TA0ML
|
Aplindore | Palindore
|
DYJIKHYBKVODAC-ZDUSSCGKSA-N
|
DB06621
| null |
ARG201
| null | null | null | null |
DB06622
| null |
7-beta-Hydroxyepiandrosterone
|
25848-69-5
|
OCP3E5KD08
|
(3beta,5alpha,7beta)-3,7-Dihydroxyandrostan-17-one | 7beta-OH-Epia | 7β-Hydroxyepiandrosterone | 7β-OH-EPIA
|
VFPMCLQMAUVEHD-UCPSWNCLSA-N
|
DB06623
| null |
Flupirtine
|
56995-20-1
|
MOH3ET196H
|
Flupirtine | Flupirtino | Flupirtinum
|
JUUFBMODXQKSTD-UHFFFAOYSA-N
|
DB06624
| null |
Taranabant
|
701977-09-5
|
X9U622S114
|
Taranabant
|
QLYKJCMUNUWAGO-GAJHUEQPSA-N
|
DB06625
| null |
Vipadenant
|
442908-10-3
|
LDR3USH1NJ
|
Vipadenant
|
HQSBCDPYXDGTCL-UHFFFAOYSA-N
|
DB06626
| null |
Axitinib
|
319460-85-0
|
C9LVQ0YUXG
|
Axitinib | Axitinibum | N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
|
RITAVMQDGBJQJZ-FMIVXFBMSA-N
|
DB06628
| null |
IMA901
| null | null | null | null |
DB06629
| null |
Zibotentan
|
186497-07-4
|
8054MM4902
|
Zibotentan
|
FJHHZXWJVIEFGJ-UHFFFAOYSA-N
|
DB06630
| null |
Anacetrapib
|
875446-37-0
|
P7T269PR6S
|
Anacetrapib
|
MZZLGJHLQGUVPN-HAWMADMCSA-N
|
DB06633
| null |
N-chlorotaurine
|
51036-13-6
| null |
N-chlorotaurine | N-monochlorotaurine | NCT | Taurine chloramine | Taurine monochloramine | Taurochloramine
|
NMMHHSLZJLPMEG-UHFFFAOYSA-N
|
DB06634
| null |
Casopitant
|
414910-27-3
|
3B03KPM27L
|
Casopitant
|
XGGTZCKQRWXCHW-WMTVXVAQSA-N
|
DB06635
| null |
Otamixaban
|
193153-04-7
|
S173RED00L
|
Otamixaban
|
PFGVNLZDWRZPJW-OPAMFIHVSA-N
|
DB06636
| null |
Isavuconazonium
|
742049-41-8
|
VH2L779W8Q
|
Isavuconazonium
|
RSWOJTICKMKTER-QXLBVTBOSA-N
|
DB06637
| null |
Dalfampridine
|
504-24-5
|
BH3B64OKL9
|
4-Aminopyridine | 4-AP | 4-Pyridinamine | 4-Pyridylamine | Dalfampridine | Fampridina | Fampridine | Fampridinum | p-Aminopyridine | γ-Aminopyridine
|
NUKYPUAOHBNCPY-UHFFFAOYSA-N
|
DB06638
| null |
Quarfloxin
|
865311-47-3
|
8M31J5031Q
|
Itarnafloxin | Itarnafloxina | Itarnafloxine | Itarnafloxinum | Quarfloxin
|
WOQIDNWTQOYDLF-CGAIIQECSA-N
|
DB06640
| null |
Fispemifene
|
341524-89-8
|
3VZ2833V08
|
Fispemifene
|
NKZTZAQIKKGTDB-QPLCGJKRSA-N
|
DB06641
| null |
Perifosine
|
157716-52-4
|
2GWV496552
|
Perifosine
|
SZFPYBIJACMNJV-UHFFFAOYSA-N
|
DB06642
| null |
Bevasiranib
|
959961-96-7
|
DGN36694W4
|
Bevasiranib
| null |
DB06643
| null |
Denosumab
|
615258-40-7
|
4EQZ6YO2HI
|
Denosumab
| null |
DB06645
| null |
Anamorelin
|
249921-19-5
|
DD5RBA1NKF
|
Anamorelin
|
VQPFSIRUEPQQPP-MXBOTTGLSA-N
|
DB06647
| null |
Volociximab
|
558480-40-3
|
496K5Z02NW
|
Anti-alpha5beta1 integrin monoclonal antibody | Volociximab
| null |
DB06649
| null |
Priralfinamide
|
133865-88-0
|
3LPF0S0GVV
|
Priralfinamide | Ralfinamide
|
BHJIBOFHEFDSAU-LBPRGKRZSA-N
|
DB06650
| null |
Ofatumumab
|
679818-59-8
|
M95KG522R0
|
HuMax-CD20 | HuMax-CD20, 2F2 | Ofatumumab | Ofatumumabum
| null |
DB06651
| null |
DiaPep 277
|
179822-83-4
|
F8778UWB0A
| null |
VGGRNGOEDNBLPH-YJHCMWSWSA-N
|
DB06652
| null |
Vicriviroc
|
306296-47-9
|
TL515DW4QS
|
Vicriviroc
|
CNPVJJQCETWNEU-CYFREDJKSA-N
|
DB06654
| null |
Safinamide
|
133865-89-1
|
90ENL74SIG
|
Safinamida | Safinamide
|
NEMGRZFTLSKBAP-LBPRGKRZSA-N
|
DB06655
| null |
Liraglutide
|
204656-20-2
|
839I73S42A
|
Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37] | Liraglutida | Liraglutide | Liraglutide (genetical recombination) | Liraglutide (rDNA origin) | Liraglutide recombinant | Liraglutidum | N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide | N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide
| null |
DB06656
| null |
TAS-106
|
180300-43-0
|
Y3O05I09ZK
|
3'-C-Ethynylcytidine | 4-Amino-1-((2R,3R,4R,5R)-4-ethynyl-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one
|
JFIWEPHGRUDAJN-DYUFWOLASA-N
|
DB06657
| null |
Valrocemide
|
92262-58-3
|
1C7GO6OW7L
|
N-Valproylglycinamide | Valrocemide
|
RALGCAOVRLYSMA-UHFFFAOYSA-N
|
DB06659
| null |
Rostaporfin
|
284041-10-7
|
466G63QE7G
|
Rostaporfin | SnET2 | Tin ethyl etiopurpurin
|
DMAHZCZCPVOYGS-ZLSDMPCXSA-L
|
DB06660
| null |
Saredutant
|
142001-63-6
|
720U2QK8I5
|
Saredutant
|
PGKXDIMONUAMFR-AREMUKBSSA-N
|
DB06661
| null |
GMK
| null | null |
GMK vaccine
| null |
DB06662
| null |
Abetimus
|
167362-48-3
|
P3UVQ22SHK
|
Abetimus
| null |
DB06663
| null |
Pasireotide
|
396091-73-9
|
98H1T17066
|
cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-) | Pasireotida | Pasireotide | Pasiréotide | Pasireotidum
|
VMZMNAABQBOLAK-DBILLSOUSA-N
|
DB06666
| null |
Lixivaptan
|
168079-32-1
|
8F5X4B082E
|
Lixivaptan
|
PPHTXRNHTVLQED-UHFFFAOYSA-N
|
DB06669
| null |
Arverapamil
|
123932-43-4
|
3J8P56R04P
|
(R)-norverapamil
|
UPKQNCPKPOLASS-AREMUKBSSA-N
|
DB06670
| null |
Odanacatib
|
603139-19-1
|
N673F6W2VH
|
Odanacatib
|
FWIVDMJALNEADT-SFTDATJTSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.